tyrosyl-seryl(o-tert-butyl)-glycyl-phenylalanyl-leucyl-threonine has been researched along with sincalide in 1 studies
| Studies (tyrosyl-seryl(o-tert-butyl)-glycyl-phenylalanyl-leucyl-threonine) | Trials (tyrosyl-seryl(o-tert-butyl)-glycyl-phenylalanyl-leucyl-threonine) | Recent Studies (post-2010) (tyrosyl-seryl(o-tert-butyl)-glycyl-phenylalanyl-leucyl-threonine) | Studies (sincalide) | Trials (sincalide) | Recent Studies (post-2010) (sincalide) |
|---|---|---|---|---|---|
| 25 | 0 | 0 | 4,015 | 72 | 533 |
| Protein | Taxonomy | tyrosyl-seryl(o-tert-butyl)-glycyl-phenylalanyl-leucyl-threonine (IC50) | sincalide (IC50) |
|---|---|---|---|
| Cholecystokinin receptor type A | Rattus norvegicus (Norway rat) | 0.0006 | |
| Cholecystokinin receptor type A | Homo sapiens (human) | 0.0006 | |
| Gastrin/cholecystokinin type B receptor | Homo sapiens (human) | 0.001 | |
| Gastrin/cholecystokinin type B receptor | Mus musculus (house mouse) | 0.0008 | |
| Cholecystokinin receptor type A | Cavia porcellus (domestic guinea pig) | 0.0004 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dickenson, AH; Magnuson, DS; Roques, BP; Simonnet, G; Sullivan, AF | 1 |
1 other study(ies) available for tyrosyl-seryl(o-tert-butyl)-glycyl-phenylalanyl-leucyl-threonine and sincalide
| Article | Year |
|---|---|
Differential interactions of cholecystokinin and FLFQPQRF-NH2 with mu and delta opioid antinociception in the rat spinal cord.
Topics: Animals; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Evoked Potentials; Injections, Spinal; Male; Nerve Fibers; Neurons; Oligopeptides; Pain; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu; Sincalide; Spinal Cord | 1990 |